John Petrich MS RPh has directed Investigational Drug Services at the Cleveland Clinic for the past 22 years. During that time, his team has supported a wide variety of clinical trials across an international landscape. John broadly assists investigators with protocol development, while his day-to-day focus is on rational drug utilization, regulatory compliance, quality improvement, and biosafety awareness throughout the enterprise.

With the emergence of gene therapies, John has helped champion the effort to enrich guidance’s around safe handling, site preparedness, and risk evaluation for hospitals and health-systems. Accordingly, his recent work has sought to provide much needed direction to site pharmacies on gene therapy management. In 2019, John authored a review in The Journal of Pharmacy Practice titled Gene Replacement Therapy: A Primer for the Health-system Pharmacist and he presented nationally and internationally on the topic of gene therapy.

John received his Pharmacy degree from the University of Toledo and his Master’s degree from Cleveland State University. He is a long standing contributor to the American Society of Health-System Pharmacists (ASHP), and past president of the Society of Clinical Research Associates (SOCRA).